首页 > 最新文献

Obesity Medicine最新文献

英文 中文
Effect of oral probiotic supplementation in obese children: A systematic review 口服益生菌补充剂对肥胖儿童的影响:一项系统综述
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.obmed.2023.100489
Kelly de Freitas Santos , Ieda Aparecida Diniz , Nayara Ragi Baldoni , Márcia Christina Caetano Romano , Joel Alves Lamounier

The intestinal microbiota has been shown to be a potential determining factor in the development of obesity. The aim of this systematic review was to identify the effect of probiotic supplementation in children with obesity. Randomized Clinical Trials (RCTs) of interventions with the oral use of probiotics for children with obesity were considered eligible. The PubMed, Scopus, Science Direct, Web of Science, VHL, and Embase databases were used as a source of information. The risk of bias was assessed using the Cochrane Risk of bias criteria. Most of the articles included were carried out in developed countries and showed the benefits of probiotic intervention in reducing anthropometric indices in children with obesity. Future RCTs are needed to assess the effect of probiotics in the absence of weight loss strategies, in order to truly ascertain the specific benefits of probiotic strains on adiposity.

肠道微生物群已被证明是肥胖发展的潜在决定因素。本系统综述的目的是确定益生菌补充剂对肥胖儿童的影响。口服益生菌干预肥胖儿童的随机临床试验(rct)被认为是合格的。使用PubMed、Scopus、Science Direct、Web of Science、VHL和Embase数据库作为信息来源。采用Cochrane偏倚风险标准评估偏倚风险。大多数纳入的文章都是在发达国家进行的,并显示了益生菌干预在降低肥胖儿童的人体测量指数方面的益处。未来的随机对照试验需要在没有减肥策略的情况下评估益生菌的效果,以真正确定益生菌菌株对肥胖的具体益处。
{"title":"Effect of oral probiotic supplementation in obese children: A systematic review","authors":"Kelly de Freitas Santos ,&nbsp;Ieda Aparecida Diniz ,&nbsp;Nayara Ragi Baldoni ,&nbsp;Márcia Christina Caetano Romano ,&nbsp;Joel Alves Lamounier","doi":"10.1016/j.obmed.2023.100489","DOIUrl":"10.1016/j.obmed.2023.100489","url":null,"abstract":"<div><p><span>The intestinal microbiota has been shown to be a potential determining factor in the development of obesity. The aim of this </span>systematic review<span><span> was to identify the effect of probiotic supplementation in children with obesity. </span>Randomized Clinical Trials<span> (RCTs) of interventions with the oral use of probiotics for children with obesity were considered eligible. The PubMed, Scopus, Science Direct, Web of Science, VHL, and Embase databases were used as a source of information. The risk of bias was assessed using the Cochrane Risk of bias criteria. Most of the articles included were carried out in developed countries and showed the benefits of probiotic intervention in reducing anthropometric indices in children with obesity. Future RCTs are needed to assess the effect of probiotics in the absence of weight loss strategies, in order to truly ascertain the specific benefits of probiotic strains on adiposity.</span></span></p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48239854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of preoperative dyslipidemia and micronutrient status in obese patients undergoing bariatric surgery in Taif, Saudi Arabia: A retrospective study 沙特阿拉伯Taif接受减肥手术的肥胖患者术前血脂异常和微量营养素状况的评估:一项回顾性研究
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.obmed.2023.100486
Saad S. Al-Shehri , Bayan Alilyyani , Khalid Alshareef , Ashjan A. Shami , Abdulrahman Alshehri , Ahmad Alghamdi , Amal Gharib

Background and aims

Obesity is a health problem that is linked to complicated metabolic disorders, increasing the risk of developing cardiovascular diseases, insulin resistance, and cancer. The aim of this study was to investigate the preoperative impact of morbid obesity on lipids and micronutrient status.

Methods

This was a retrospective study conducted at King Abdulaziz Specialist Hospital, Taif, Saudi Arabia. A total of 142 obese individuals who were candidates for operation were recruited. Data were obtained from participants’ records, including lipids, HbA1c, RBCs, hemoglobin, iron, ferritin, vitamin B12, and vitamin D.

Results

The study population comprised 57% women; the mean age was 35.9 ± 9.40 years and BMI was 45.1 ± 6.35 kg/m2. Abnormal lipid profiles were found in 34% for TG, 34.5% for TC, 83.3% for HDL-C, and 73.9% for LDL-C. The degree of dyslipidemia was significantly higher in patients with increased HbA1c. The study found a prevalence of MCV (38.4%), hemoglobin (20.4%), iron (9%), and ferritin (35%) deficiency, accompanied by RBC elevation in 34% of cases. Vitamins D and B12 were correlated with BMI, and a higher prevalence (82.6%) of vitamin D deficiency was observed.

Conclusion

The study cohort had significant dyslipidemia, especially those with elevated HbA1c. Micronutrient deficiency was seen prior to bariatric surgery. Determining preoperative micronutrient status could aid in supplementing patients prior to operation and optimizing nutritional treatment afterward.

背景和目的肥胖是一种健康问题,与复杂的代谢紊乱有关,增加了患心血管疾病、胰岛素抵抗和癌症的风险。本研究的目的是调查术前病态肥胖对血脂和微量营养素状况的影响。方法回顾性研究在沙特阿拉伯塔伊夫阿卜杜勒阿齐兹国王专科医院进行。总共招募了142名肥胖患者作为手术候选人。数据来自参与者的记录,包括血脂、糖化血红蛋白、红细胞、血红蛋白、铁、铁蛋白、维生素B12和维生素d。平均年龄35.9±9.40岁,BMI为45.1±6.35 kg/m2。血脂异常的比例分别为TG的34%、TC的34.5%、HDL-C的83.3%和LDL-C的73.9%。HbA1c升高的患者血脂异常程度明显增高。研究发现,34%的患者存在MCV(38.4%)、血红蛋白(20.4%)、铁(9%)和铁蛋白(35%)缺乏症,并伴有红细胞升高。维生素D和B12与BMI相关,维生素D缺乏症的患病率较高(82.6%)。结论研究队列存在明显的血脂异常,尤其是HbA1c升高的患者。在减肥手术前发现微量营养素缺乏。术前微量营养素状况的确定有助于术前补充患者的营养和术后优化营养治疗。
{"title":"Evaluation of preoperative dyslipidemia and micronutrient status in obese patients undergoing bariatric surgery in Taif, Saudi Arabia: A retrospective study","authors":"Saad S. Al-Shehri ,&nbsp;Bayan Alilyyani ,&nbsp;Khalid Alshareef ,&nbsp;Ashjan A. Shami ,&nbsp;Abdulrahman Alshehri ,&nbsp;Ahmad Alghamdi ,&nbsp;Amal Gharib","doi":"10.1016/j.obmed.2023.100486","DOIUrl":"10.1016/j.obmed.2023.100486","url":null,"abstract":"<div><h3>Background and aims</h3><p><span>Obesity is a health problem that is linked to complicated </span>metabolic disorders<span>, increasing the risk of developing cardiovascular diseases, insulin resistance, and cancer. The aim of this study was to investigate the preoperative impact of morbid obesity on lipids and micronutrient status.</span></p></div><div><h3>Methods</h3><p>This was a retrospective study conducted at King Abdulaziz Specialist Hospital, Taif, Saudi Arabia. A total of 142 obese individuals who were candidates for operation were recruited. Data were obtained from participants’ records, including lipids, HbA1c<span><span>, RBCs<span>, hemoglobin, iron, ferritin, </span></span>vitamin B12<span>, and vitamin D.</span></span></p></div><div><h3>Results</h3><p>The study population comprised 57% women; the mean age was 35.9 ± 9.40 years and BMI was 45.1 ± 6.35 kg/m<sup>2</sup><span><span><span>. Abnormal lipid profiles were found in 34% for TG, 34.5% for TC, 83.3% for HDL-C, and 73.9% for LDL-C. The degree of </span>dyslipidemia was significantly higher </span>in patients<span> with increased HbA1c. The study found a prevalence of MCV (38.4%), hemoglobin (20.4%), iron (9%), and ferritin (35%) deficiency, accompanied by RBC elevation in 34% of cases. Vitamins D and B12 were correlated with BMI, and a higher prevalence (82.6%) of vitamin D deficiency was observed.</span></span></p></div><div><h3>Conclusion</h3><p><span>The study cohort had significant dyslipidemia, especially those with elevated HbA1c. Micronutrient deficiency was seen prior to </span>bariatric surgery<span>. Determining preoperative micronutrient status could aid in supplementing patients prior to operation and optimizing nutritional treatment afterward.</span></p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47073610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginger extract ameliorates endocrine-metabolic disturbances in letrozole-induced PCOS mice model by altering androgen-adiponectin status 生姜提取物通过改变雄激素脂联素状态改善来曲唑诱导的多囊卵巢综合征小鼠模型的内分泌代谢紊乱
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.obmed.2023.100485
Mohd Zahoor ul haq Shah , Vinoy Kumar Shrivastava , Manzoor Ahmad Mir

Purpose

Polycystic ovarian syndrome (PCOS) has an impact on numerous women's health issues worldwide. Since the specific aetiology is unknown, the diagnostic criteria are currently insufficient, which contributes to the under diagnosis and under treatment of PCOS in many women.

Basic procedure

Eighteen mature Parkes strain mice (4–5 weeks old) weighing 18–21 g were at random separated to three groups with six mice each: Group I served as the control; Group II was given Letrozole (LET) dissolved in normal saline water (0.9%) orally by using oral gavage at the dose of (6 mg/kg bw) for twenty one days to induce PCOS followed by 60 days without treatment; Group III was given LET (6 mg/kg) for the twenty one days, followed by the oral gavage treatment of ginger (350 mg/kg bw orally daily) for 60 days.

Main findings

In our study we observed that mice with PCOS had increased body weight, ovary mass, blood glucose, insulin, Homa insulin resistance (IR), cholesterol, low-density lipoprotein (LDL), very low-density lipoprotein (VLDL) and interleukin-6 (IL-6) as well as increase in testosterone, and luteinizing hormone (LH). We observed decline in estrogen, follicle stimulating hormone (FSH) and decreased antioxidant capacity in the ovary. These alterations were linked to decreased adiponectin in mice. However after ginger administration these changes were reversed.

Conclusion

The findings from our research suggested that adiponectin has direct impact on metabolic and endocrine facets of PCOS, & its drop can cause women infertility. Therefore, boosting the circulation of adiponectin may be employed as a remedy to metabolic, and perhaps endocrine, conditions in polycystic ovarian syndrome-affected individuals.

目的多囊卵巢综合征(PCOS)影响着世界范围内许多妇女的健康问题。由于具体病因不明,目前诊断标准不足,导致许多妇女对多囊卵巢综合征的诊断和治疗不足。基本操作将18只4 ~ 5周龄、体重18 ~ 21 g的成熟Parkes系小鼠随机分为3组,每组6只:1组为对照组;II组小鼠给予生理盐水(0.9%)溶解来曲唑(LET),以(6 mg/kg bw)剂量灌胃21 d诱导PCOS, 60 d不给药;第三组大鼠给予LET (6 mg/kg)治疗21 d,随后灌胃生姜(350 mg/kg bw每日口服)治疗60 d。在我们的研究中,我们观察到PCOS小鼠的体重、卵巢质量、血糖、胰岛素、Homa胰岛素抵抗(IR)、胆固醇、低密度脂蛋白(LDL)、极低密度脂蛋白(VLDL)和白细胞介素-6 (IL-6)增加,睾酮和黄体生成素(LH)增加。我们观察到卵巢雌激素、促卵泡激素(FSH)和抗氧化能力下降。这些变化与小鼠体内脂联素的减少有关。然而,服用生姜后,这些变化被逆转。结论脂联素对PCOS的代谢和内分泌有直接影响。它的下降会导致女性不孕。因此,促进脂联素的循环可能被用作治疗多囊卵巢综合征患者代谢和内分泌状况的药物。
{"title":"Ginger extract ameliorates endocrine-metabolic disturbances in letrozole-induced PCOS mice model by altering androgen-adiponectin status","authors":"Mohd Zahoor ul haq Shah ,&nbsp;Vinoy Kumar Shrivastava ,&nbsp;Manzoor Ahmad Mir","doi":"10.1016/j.obmed.2023.100485","DOIUrl":"10.1016/j.obmed.2023.100485","url":null,"abstract":"<div><h3>Purpose</h3><p><span>Polycystic ovarian syndrome (PCOS) has an impact on numerous </span>women's health<span> issues worldwide. Since the specific aetiology is unknown, the diagnostic criteria are currently insufficient, which contributes to the under diagnosis and under treatment of PCOS in many women.</span></p></div><div><h3>Basic procedure</h3><p>Eighteen mature Parkes strain mice (4–5 weeks old) weighing 18–21 g were at random separated to three groups with six mice each: Group I served as the control; Group II was given Letrozole (LET) dissolved in normal saline water (0.9%) orally by using oral gavage at the dose of (6 mg/kg bw) for twenty one days to induce PCOS followed by 60 days without treatment; Group III was given LET (6 mg/kg) for the twenty one days, followed by the oral gavage treatment of ginger (350 mg/kg bw orally daily) for 60 days.</p></div><div><h3>Main findings</h3><p>In our study we observed that mice with PCOS had increased body weight, ovary mass, blood glucose, insulin, Homa insulin resistance (IR), cholesterol, low-density lipoprotein (LDL), very low-density lipoprotein (VLDL) and interleukin-6 (IL-6) as well as increase in testosterone, and luteinizing hormone<span><span> (LH). We observed decline in estrogen, follicle stimulating hormone (FSH) and decreased </span>antioxidant capacity<span> in the ovary. These alterations were linked to decreased adiponectin in mice. However after ginger administration these changes were reversed.</span></span></p></div><div><h3>Conclusion</h3><p>The findings from our research suggested that adiponectin has direct impact on metabolic and endocrine facets of PCOS, &amp; its drop can cause women infertility. Therefore, boosting the circulation of adiponectin may be employed as a remedy to metabolic, and perhaps endocrine, conditions in polycystic ovarian syndrome-affected individuals.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43282636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percentage of excess body mass index loss and cardiometabolic risk reduction in Peruvian adults undergoing sleeve gastrectomy 秘鲁成人进行袖式胃切除术后超重体重指数损失和心脏代谢风险降低的百分比
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.obmed.2023.100488
María Luisa Bardelli , Marycielo Neciosup-Leon , Carlos S. Castilla-Espinoza , Luciana Torres-Pesantes , Paola K. Rodrigo-Gallardo , Medalit E. Huamanchumo-Suyon , Guido Bendezu-Quispe , Gustavo Salinas-Sedo , Carlos J. Toro-Huamanchumo

Objective

To assess the association between the percentage of excess body mass index loss (%EBMIL) and cardiometabolic risk reduction in Peruvian adults undergoing laparoscopic sleeve gastrectomy (LSG).

Methods

Retrospective cohort study conducted with adult patients who underwent LSG in a bariatric clinic during 2016–2020. The outcome variable was cardiometabolic risk change (expressed in Δ) 1 year after LSG. To that effect, the variables total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, very LDL (VLDL) cholesterol, triglycerides, glucose, insulin, and HOMA-IR at baseline and after 12 months were considered. The exposure variable was %EBMIL. Crude and adjusted β coefficients were estimated with linear regression models.

Results

Of the 110 patients analyzed, 68.2% were women, and the median patient age was 34.5 years. In the model adjusted for sex, age, and baseline BMI, we noted that each 25% increase in %EBMIL resulted in a decrease in the values for total cholesterol, LDL, triglycerides, and insulin by 10.36 mg/dL (p < 0.001), 7.98 mg/dL (p = 0.001), 13.35 mg/dL (p = 0.033), and 3.63 uU/mL (p = 0.040), respectively.

Conclusion

%EBMIL was associated with a decrease in total cholesterol, LDL, triglycerides, and insulin levels, which could suggest a favorable cardiometabolic evolution during the first 12 months following LSG.

目的评估秘鲁成人腹腔镜袖式胃切除术(LSG)患者超重体重指数损失百分比(% ebil)与心脏代谢风险降低之间的关系。方法对2016-2020年在减肥诊所接受LSG治疗的成年患者进行回顾性队列研究。结果变量为LSG后1年的心脏代谢风险变化(以Δ表示)。为此,考虑了基线和12个月后总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白(LDL)胆固醇、极低密度脂蛋白(VLDL)胆固醇、甘油三酯、葡萄糖、胰岛素和HOMA-IR等变量。暴露变量为%EBMIL。粗β系数和调整后的β系数用线性回归模型估计。结果110例患者中,女性占68.2%,中位年龄为34.5岁。在对性别、年龄和基线BMI进行调整的模型中,我们注意到EBMIL每增加25%,总胆固醇、低密度脂蛋白、甘油三酯和胰岛素的值就会下降10.36 mg/dL (p <0.001), 7.98 mg / dL (p = 0.001), 13.35 mg / dL (p = 0.033),和3.63 uU /毫升(p = 0.040),分别。结论:EBMIL与总胆固醇、低密度脂蛋白、甘油三酯和胰岛素水平的降低有关,这可能表明在LSG后的前12个月有利的心脏代谢进化。
{"title":"Percentage of excess body mass index loss and cardiometabolic risk reduction in Peruvian adults undergoing sleeve gastrectomy","authors":"María Luisa Bardelli ,&nbsp;Marycielo Neciosup-Leon ,&nbsp;Carlos S. Castilla-Espinoza ,&nbsp;Luciana Torres-Pesantes ,&nbsp;Paola K. Rodrigo-Gallardo ,&nbsp;Medalit E. Huamanchumo-Suyon ,&nbsp;Guido Bendezu-Quispe ,&nbsp;Gustavo Salinas-Sedo ,&nbsp;Carlos J. Toro-Huamanchumo","doi":"10.1016/j.obmed.2023.100488","DOIUrl":"10.1016/j.obmed.2023.100488","url":null,"abstract":"<div><h3>Objective</h3><p><span>To assess the association between the percentage of excess body mass index loss (%EBMIL) and cardiometabolic risk reduction in Peruvian adults undergoing </span>laparoscopic sleeve gastrectomy (LSG).</p></div><div><h3>Methods</h3><p><span>Retrospective cohort study<span><span> conducted with adult patients who underwent LSG in a bariatric clinic during 2016–2020. The outcome variable was cardiometabolic risk change (expressed in Δ) 1 year after LSG. To that effect, the variables total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, very LDL (VLDL) cholesterol, </span>triglycerides, glucose, insulin, and HOMA-IR at baseline and after 12 months were considered. The exposure variable was %EBMIL. Crude and adjusted β coefficients were estimated with </span></span>linear regression models.</p></div><div><h3>Results</h3><p>Of the 110 patients analyzed, 68.2% were women, and the median patient age was 34.5 years. In the model adjusted for sex, age, and baseline BMI, we noted that each 25% increase in %EBMIL resulted in a decrease in the values for total cholesterol, LDL, triglycerides, and insulin by 10.36 mg/dL (p &lt; 0.001), 7.98 mg/dL (p = 0.001), 13.35 mg/dL (p = 0.033), and 3.63 uU/mL (p = 0.040), respectively.</p></div><div><h3>Conclusion</h3><p>%EBMIL was associated with a decrease in total cholesterol, LDL, triglycerides, and insulin levels, which could suggest a favorable cardiometabolic evolution during the first 12 months following LSG.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45788788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tirzepatide, a new class of incretin-based drug for diabetes 替西帕肽,一种新型的以肠促胰岛素为基础的糖尿病药物
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.obmed.2023.100483
Tianru Jin
{"title":"Tirzepatide, a new class of incretin-based drug for diabetes","authors":"Tianru Jin","doi":"10.1016/j.obmed.2023.100483","DOIUrl":"10.1016/j.obmed.2023.100483","url":null,"abstract":"","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42717236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quercetin as a noteworthy treatment for polycystic ovary syndrome: An evidence-based review from molecular basis mechanism to clinical perspective 槲皮素治疗多囊卵巢综合征值得注意:从分子基础机制到临床的循证综述
Q2 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.obmed.2023.100490
Muhammad Habiburrahman , Muhammad Prasetio Wardoyo , Afid Brilliana Putra , Ilham Utama Surya , Gita Pratama

Polycystic ovary syndrome (PCOS) is a complex endocrinopathy that often occurs in reproductive-age women and causes anovulatory infertility problems. Current management guidelines, including fertility medications, hormonal therapy, and glycemic control, have drawbacks due to their limited efficacy and undesirable outcomes. Therefore, this review intended to scrutinise the mechanism and potential benefits of a candidate herbal therapy for PCOS, quercetin, as an adjunctive medication to alleviate disease manifestations. Articles were searched in PubMed, EBSCOHost, ProQuest, and Scopus databases and screened based on their titles and abstracts. A critical appraisal was done using an Evidence-Based Medicine worksheet. Fourteen eligible articles were obtained, including one systematic review, four randomized clinical trials; eight experimental studies; and one systematic pharmacological strategy-based research. It was shown that quercetin alleviated insulin resistance via activating phosphatidylinositol 3-kinase (PI3–K) signalling, reduced testosterone, controlled luteinising hormone, and had anti-inflammatory effects on the ovaries. This antioxidant also altered catabolism and steroidogenesis, regulated AMP-activated protein kinase (AMPK), and decreased oocyte nucleation failure. Furthermore, the lipid profile was reduced by quercetin through the modulation of adiponectin receptors. Ultimately, quercetin successfully improved the pregnancy rate. Due to its potential to modulate several pathways involved in metabolic disease and infertility, quercetin is a promising candidate in clinical practice as adjunctive therapy for PCOS.

多囊卵巢综合征(PCOS)是一种复杂的内分泌疾病,常见于育龄妇女,可引起无排卵性不孕问题。目前的管理指南,包括生育药物、激素治疗和血糖控制,由于其有限的疗效和不良后果而存在缺陷。因此,本综述旨在探讨槲皮素作为PCOS的一种候选草药治疗的机制和潜在益处,槲皮素作为一种辅助药物来缓解疾病的表现。在PubMed、EBSCOHost、ProQuest和Scopus数据库中检索文章,并根据标题和摘要进行筛选。使用循证医学工作表进行关键评估。纳入14篇符合条件的文章,包括1篇系统综述,4篇随机临床试验;8项实验研究;一个系统的基于药理策略的研究。槲皮素通过激活磷脂酰肌醇3-激酶(PI3-K)信号,降低睾酮,控制黄体生成素,并对卵巢具有抗炎作用来减轻胰岛素抵抗。这种抗氧化剂还能改变分解代谢和类固醇生成,调节amp激活的蛋白激酶(AMPK),并减少卵母细胞成核失败。此外,槲皮素通过调节脂联素受体降低了脂质谱。最终,槲皮素成功地提高了怀孕率。由于槲皮素具有调节代谢疾病和不孕症的多种途径的潜力,因此在临床实践中,槲皮素作为多囊卵巢综合征的辅助治疗是一个很有前途的候选者。
{"title":"Quercetin as a noteworthy treatment for polycystic ovary syndrome: An evidence-based review from molecular basis mechanism to clinical perspective","authors":"Muhammad Habiburrahman ,&nbsp;Muhammad Prasetio Wardoyo ,&nbsp;Afid Brilliana Putra ,&nbsp;Ilham Utama Surya ,&nbsp;Gita Pratama","doi":"10.1016/j.obmed.2023.100490","DOIUrl":"10.1016/j.obmed.2023.100490","url":null,"abstract":"<div><p><span><span><span><span>Polycystic ovary syndrome<span> (PCOS) is a complex endocrinopathy that often occurs in reproductive-age women and causes anovulatory infertility problems. Current management guidelines, including fertility medications, hormonal therapy, and </span></span>glycemic control, have drawbacks due to their limited efficacy and undesirable outcomes. Therefore, this review intended to scrutinise the mechanism and potential benefits of a candidate </span>herbal therapy for PCOS, </span>quercetin, as an adjunctive medication to alleviate disease manifestations. Articles were searched in PubMed, EBSCOHost, ProQuest, and Scopus databases and screened based on their titles and abstracts. A critical appraisal was done using an Evidence-Based Medicine worksheet. Fourteen eligible articles were obtained, including one </span>systematic review<span><span>, four randomized clinical trials<span>; eight experimental studies; and one systematic pharmacological strategy-based research. It was shown that quercetin alleviated insulin resistance via activating phosphatidylinositol 3-kinase (PI3–K) signalling, reduced testosterone, controlled luteinising hormone<span>, and had anti-inflammatory effects on the ovaries. This antioxidant also altered catabolism and steroidogenesis<span>, regulated AMP-activated protein kinase (AMPK), and decreased oocyte nucleation failure. Furthermore, the lipid profile was reduced by quercetin through the modulation of adiponectin receptors. Ultimately, quercetin successfully improved the pregnancy rate. Due to its potential to modulate several pathways involved in </span></span></span></span>metabolic disease and infertility, quercetin is a promising candidate in clinical practice as adjunctive therapy for PCOS.</span></p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44243812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical activity and dietary habits in patients with asthma: How is it related to asthma control? 哮喘患者的体育活动和饮食习惯:它与哮喘控制有何关系?
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.obmed.2022.100474
Ömür Aydın , Zeynep Çelebi Sözener , Dilşad Mungan , Ümüş Özbey , Serap Balaban , Derya Gökmen , Ali Murat Zergeroğlu , Bilun Gemicioğlu , Arzu Yorgancıoğlu , Yavuz Havlucu , Füsun Yıldız , Serap Argun Barış , Pamir Çerçi , Adile Berna Dursun , Füsun Kalpaklıoğlu , Ayşe Baççıoğlu , Sibel Atış Naycı , Eylem Sercan Özgür , Reşat Kendirlinan , İlkay Koca Kalkan , Gülfem Çelik

Aims

In this study, we aimed to determine the PA and dietary habits of patients with asthma and whether asthma control had a role in these habits.

Methods

Adult patients with asthma were included. Three questionnaires were administered to the patients. and daily step counts were recorded for one week. Asthma control level and severe asthma attacks in the previous year were assessed.

Results

A total of 277 patients were included. One hundred eighty-two (65.3%) of the patients were overweight/obese. According to FFQ, none of the food groups were comsumed in recommended levels. According to the IPAQ scores, 82.7% of the patients had mild physical activity. The daily step counts and the PA domain of the HLBS-II in obese patients were lower than the nonobese patients (p = 0.001 and p = 0.034,respectively). The rate of obese patients (n = 9; 50%) was higher in the uncontrolled patients.

Conclusion

In our study, the majority of patients were physically inactive. Few patients consumed the recommended amount of foods. Being overweight seems to be a significant barrier to the healthy life behaviors. Although these behaviours do not seem to have an effect on asthma controlling this study, further prospective placebo-controlled studies are needed.

目的在本研究中,我们旨在确定哮喘患者的PA和饮食习惯,以及哮喘控制是否在这些习惯中起作用。方法纳入成人哮喘患者。对患者进行了三份问卷调查。他们记录了一周内每天的步数。评估前一年哮喘控制水平和严重哮喘发作情况。结果共纳入277例患者。182例(65.3%)患者超重/肥胖。根据FFQ的调查,没有一组食物的摄取量达到建议水平。根据IPAQ评分,82.7%的患者有轻度体育活动。肥胖患者的日步数和HLBS-II蛋白PA结构域均低于非肥胖患者(p = 0.001和p = 0.034)。肥胖患者比率(n = 9;50%)在未控制的患者中更高。结论在我们的研究中,大多数患者缺乏运动。很少有病人食用了推荐量的食物。超重似乎是健康生活行为的一个重要障碍。虽然这些行为在本研究中似乎对哮喘控制没有影响,但还需要进一步的前瞻性安慰剂对照研究。
{"title":"Physical activity and dietary habits in patients with asthma: How is it related to asthma control?","authors":"Ömür Aydın ,&nbsp;Zeynep Çelebi Sözener ,&nbsp;Dilşad Mungan ,&nbsp;Ümüş Özbey ,&nbsp;Serap Balaban ,&nbsp;Derya Gökmen ,&nbsp;Ali Murat Zergeroğlu ,&nbsp;Bilun Gemicioğlu ,&nbsp;Arzu Yorgancıoğlu ,&nbsp;Yavuz Havlucu ,&nbsp;Füsun Yıldız ,&nbsp;Serap Argun Barış ,&nbsp;Pamir Çerçi ,&nbsp;Adile Berna Dursun ,&nbsp;Füsun Kalpaklıoğlu ,&nbsp;Ayşe Baççıoğlu ,&nbsp;Sibel Atış Naycı ,&nbsp;Eylem Sercan Özgür ,&nbsp;Reşat Kendirlinan ,&nbsp;İlkay Koca Kalkan ,&nbsp;Gülfem Çelik","doi":"10.1016/j.obmed.2022.100474","DOIUrl":"10.1016/j.obmed.2022.100474","url":null,"abstract":"<div><h3>Aims</h3><p>In this study, we aimed to determine the PA and dietary habits of patients with asthma and whether asthma control had a role in these habits.</p></div><div><h3>Methods</h3><p>Adult patients with asthma were included. Three questionnaires were administered to the patients. and daily step counts were recorded for one week. Asthma control level and severe asthma attacks in the previous year were assessed.</p></div><div><h3>Results</h3><p>A total of 277 patients were included. One hundred eighty-two (65.3%) of the patients were overweight/obese. According to FFQ, none of the food groups were comsumed in recommended levels. According to the IPAQ scores, 82.7% of the patients had mild physical activity. The daily step counts and the PA domain of the HLBS-II in obese patients were lower than the nonobese patients (p = 0.001 and p = 0.034,respectively). The rate of obese patients (n = 9; 50%) was higher in the uncontrolled patients.</p></div><div><h3>Conclusion</h3><p>In our study, the majority of patients were physically inactive. Few patients consumed the recommended amount of foods. Being overweight seems to be a significant barrier to the healthy life behaviors. Although these behaviours do not seem to have an effect on asthma controlling this study, further prospective placebo-controlled studies are needed.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47651867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A retrospective study assessing the effects of bariatric surgery on comorbid conditions and quality of life in obese individuals 评估减肥手术对肥胖患者合并症和生活质量影响的回顾性研究
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.obmed.2023.100479
Kashif Irshad , Ali Hazrati , Nabil Merchant , Ally Auzad , Shannon Pereira

Background

The primary aim of this study is to report on changes in obese patients’ comorbidities before and after gastric sleeve surgery. We also want to assess the safety outcomes of performing bariatric surgery at an ambulatory surgical facility by recording the number of complications after surgery.

Methods

This is a retrospective observational study which quantifies the impact of laparoscopic gastric sleeve surgery on the treatment of obesity and its comorbidities among adults 18 and over (n = 219) with a minimum BMI of 30. Pre-operatively, obesity related comorbidities were reported using an in-person medical assessment. Post-operatively, patients were contacted for reassessment through a survey-based questionnaire. The changes in patients’ comorbidities were recorded and quantified.

Results

A total of 219 patients, 177 women (80.8%) and 42 men (19.2%), with a mean age of 41.6 years and an average BMI of 37.3 underwent gastric sleeve surgery. There were three reported complications post-op, and no deaths were reported as a result of the surgery. Moreover, an exact McNemar's test determined a statistically significant difference between the number of self-reported comorbidities in pre-operation (M = 0.8) vs post-operation (M = 0.2); t (218) = 10.61, p = .05. Improvements were seen in the incidence of diabetes, sleep apnea, hypertension, Gastroesophageal reflux disease (GERD), and chronic pain.

Conclusion

The findings suggest significant improvement in weight loss and obesity-related comorbidities such as diabetes, sleep apnea, hypertension, and GERD, among patients who underwent the gastric sleeve surgery. Moreover, the low number of complications suggest that successful surgery can be safely performed in an outpatient setting.

本研究的主要目的是报道肥胖患者在胃袖手术前后合并症的变化。我们还想通过记录术后并发症的数量来评估在门诊手术设施进行减肥手术的安全性。方法本研究是一项回顾性观察性研究,量化了18岁及以上、BMI最低为30的成人(n = 219)腹腔镜胃套管手术对肥胖及其合并症治疗的影响。术前,肥胖相关的合并症报告使用现场医疗评估。术后,通过问卷调查的方式联系患者进行再评估。记录并量化患者合并症的变化。结果219例患者行胃套管手术,其中女性177例(80.8%),男性42例(19.2%),平均年龄41.6岁,平均BMI 37.3。据报道有3例术后并发症,无手术死亡报告。此外,精确的McNemar检验确定了术前(M = 0.8)与术后(M = 0.2)自我报告的合并症数量之间的统计学显著差异;T (218) = 10.61, p = 0.05。糖尿病、睡眠呼吸暂停、高血压、胃食管反流病(GERD)和慢性疼痛的发生率均有改善。结论:研究结果表明,在接受胃套手术的患者中,体重减轻和肥胖相关的合并症如糖尿病、睡眠呼吸暂停、高血压和胃反流有显著改善。此外,低数量的并发症表明,成功的手术可以安全地进行门诊设置。
{"title":"A retrospective study assessing the effects of bariatric surgery on comorbid conditions and quality of life in obese individuals","authors":"Kashif Irshad ,&nbsp;Ali Hazrati ,&nbsp;Nabil Merchant ,&nbsp;Ally Auzad ,&nbsp;Shannon Pereira","doi":"10.1016/j.obmed.2023.100479","DOIUrl":"10.1016/j.obmed.2023.100479","url":null,"abstract":"<div><h3>Background</h3><p><span>The primary aim of this study is to report on changes in obese patients’ comorbidities before and after gastric sleeve surgery. We also want to assess the safety outcomes of performing </span>bariatric surgery at an ambulatory surgical facility by recording the number of complications after surgery.</p></div><div><h3>Methods</h3><p>This is a retrospective observational study which quantifies the impact of laparoscopic gastric sleeve surgery on the treatment of obesity and its comorbidities among adults 18 and over (n = 219) with a minimum BMI of 30. Pre-operatively, obesity related comorbidities were reported using an in-person medical assessment. Post-operatively, patients were contacted for reassessment through a survey-based questionnaire. The changes in patients’ comorbidities were recorded and quantified.</p></div><div><h3>Results</h3><p>A total of 219 patients, 177 women (80.8%) and 42 men (19.2%), with a mean age of 41.6 years and an average BMI of 37.3 underwent gastric sleeve surgery. There were three reported complications post-op, and no deaths were reported as a result of the surgery. Moreover, an exact McNemar's test<span> determined a statistically significant difference between the number of self-reported comorbidities in pre-operation (M = 0.8) vs post-operation (M = 0.2); t (218) = 10.61, p = .05. Improvements were seen in the incidence of diabetes, sleep apnea<span>, hypertension, Gastroesophageal reflux disease (GERD), and chronic pain.</span></span></p></div><div><h3>Conclusion</h3><p>The findings suggest significant improvement in weight loss and obesity-related comorbidities such as diabetes, sleep apnea, hypertension, and GERD, among patients who underwent the gastric sleeve surgery. Moreover, the low number of complications suggest that successful surgery can be safely performed in an outpatient setting.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47669436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early- or adult-onset obesity has a similar cardiometabolic profile and weight loss response to clinical treatment in adulthood 早期或成年发病的肥胖对成年临床治疗有相似的心脏代谢特征和体重减轻反应
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.obmed.2022.100475
Marta Germano Prado , Patrícia Teófilo Monteagudo , Glaucia Carneiro , Maria Teresa Zanella , Bianca de Almeida-Pititto

Aims

We aimed to evaluate the relationship between the period of obesity onset in the life cycle of obese adults with their cardiometabolic profile and response to clinical treatment.

Methods

A cross-sectional study carried out in 124 individuals, ≥18 years old, who received clinical treatment for obesity based on the same protocol of care and were stratified according to the period of obesity onset in childhood/adolescence (early) or adulthood (adult). Cardiometabolic profiles (e.g., hypertension, dyslipidemia and diabetes) and weight loss during clinical treatment (mean follow-up of 2 years) were compared among the groups. A ≥10% weight loss of the baseline weight was considered a successful response to clinical treatment.

Results

Early-onset obesity group (n = 40) was younger at the beginning of follow-up [35.8(10.3) vs. 47.9(10.5) years, p < 0.001] and presented a higher frequency of BMI≥40kg/m2 [29(72.5) vs. 42(50.0) %, p = 0.018)] than the adult-onset obesity group (n = 84). Duration of obesity and of follow-up was similar in both groups as well as mean weight loss during the treatment and frequencies of hypertension, diabetes, pre-diabetes or dyslipidemia.

Conclusions

Weight loss response to clinical treatment of obesity as well as prevalence of cardiometabolic risk factors were similar in early- and adult-onset obesity.

目的:我们旨在评估肥胖成年人生命周期中肥胖发作期与其心脏代谢状况和临床治疗反应之间的关系。方法对124名≥18岁的肥胖患者进行横断面研究,这些患者根据相同的护理方案接受肥胖临床治疗,并根据儿童/青少年(早期)或成年(成年)的肥胖发病期进行分层。比较各组的心脏代谢状况(如高血压、血脂异常和糖尿病)和临床治疗期间的体重减轻(平均随访2年)。基线体重减轻≥10%被认为是对临床治疗的成功反应。结果早发性肥胖组(n=40)在随访开始时更年轻[35.8(10.3)vs.47.9(10.5)岁,p<;0.001],BMI≥40kg/m2的频率高于成人期肥胖组(n=84)[29(72.5)vs.42(50.0)%,p=0.018)]。两组的肥胖持续时间和随访时间相似,治疗期间的平均体重减轻以及高血压、糖尿病、糖尿病前期或血脂异常的频率相似。结论早期和成人肥胖患者对肥胖临床治疗的减肥反应以及心脏代谢危险因素的患病率相似。
{"title":"Early- or adult-onset obesity has a similar cardiometabolic profile and weight loss response to clinical treatment in adulthood","authors":"Marta Germano Prado ,&nbsp;Patrícia Teófilo Monteagudo ,&nbsp;Glaucia Carneiro ,&nbsp;Maria Teresa Zanella ,&nbsp;Bianca de Almeida-Pititto","doi":"10.1016/j.obmed.2022.100475","DOIUrl":"https://doi.org/10.1016/j.obmed.2022.100475","url":null,"abstract":"<div><h3>Aims</h3><p>We aimed to evaluate the relationship between the period of obesity onset in the life cycle of obese adults with their cardiometabolic profile and response to clinical treatment.</p></div><div><h3>Methods</h3><p>A cross-sectional study carried out in 124 individuals, ≥18 years old, who received clinical treatment for obesity based on the same protocol of care and were stratified according to the period of obesity onset in childhood/adolescence (early) or adulthood (adult). Cardiometabolic profiles (e.g., hypertension, dyslipidemia and diabetes) and weight loss during clinical treatment (mean follow-up of 2 years) were compared among the groups. A ≥10% weight loss of the baseline weight was considered a successful response to clinical treatment.</p></div><div><h3>Results</h3><p>Early-onset obesity group (n = 40) was younger at the beginning of follow-up [35.8(10.3) <em>vs.</em> 47.9(10.5) years, p &lt; 0.001] and presented a higher frequency of BMI≥40kg/m<sup>2</sup> [29(72.5) vs. 42(50.0) %, p = 0.018)] than the adult-onset obesity group (n = 84). Duration of obesity and of follow-up was similar in both groups as well as mean weight loss during the treatment and frequencies of hypertension, diabetes, pre-diabetes or dyslipidemia.</p></div><div><h3>Conclusions</h3><p>Weight loss response to clinical treatment of obesity as well as prevalence of cardiometabolic risk factors were similar in early- and adult-onset obesity.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49719819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underweight, overweight, obesity and associated factors among elementary school children: A cross-sectional study in Kerman province, Iran 伊朗克尔曼省小学生体重过轻、超重、肥胖及其相关因素的横断面研究
Q2 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.obmed.2023.100477
Mojgan Sanjari , Ladan Amirkhosravi , Seyed Ehsan Hosseini , Mahzad tavakolinejad kermani , Farzaneh Abdollahi , Atefeh Maghfoori , Mostafa Eghbalian

Background

Childhood weight abnormalities are often considered a global health issue with several consequences. This study was conducted to determine the prevalence of underweight, overweight and obesity, and also identify associated factors in elementary school children.

Materials and methods

A total of 1579 elementary school students out of 70000 in the academic year 2014–2015 were selected to participate in this cross-sectional study, using two-stage cluster random sampling. Students' height and weight were measured and their body mass index (BMI) was calculated. Weight status was determined by age and sex according to BMI percentiles of the Center for Disease Control (CDC) standards and based on the percentiles calculated by SPSS in the studied population. Percentiles of more than 95, between 85 and 95, and less than 5 were considered as obese, overweight, and under-weight, respectively. Age, gender, level of parent's education, parent's occupation, place of residence, type of school, monthly income, nutritional status and time of starting complementary feeding, were collected by an information form. Data were analyzed by SPSS software.

Results

According to BMI percentile of CDC, the prevalence of obesity, overweight and underweight among students was 9%, 10% and 17%, respectively. A significant correlation was observed between age, type of school, place of residence, and students' nutrition with weight abnormalities. Also, parents’ education, birth weight, time of starting complementary feeding, hours of watching television and playing computer games, and physical activity rate had no significant relationship with weight abnormalities of students.

Conclusion

Weight abnormalities are one of the most common health problems among elementary school students living in Kerman city, Iran. Overall, more than 35% of children participated in this study had some form of weight abnormalities. Underweight is considered a health issue in our society, the same as obesity and overweight.

背景儿童体重异常通常被认为是一个全球性的健康问题,有几个后果。本研究旨在确定小学生体重不足、超重和肥胖的患病率,并确定相关因素。材料和方法2014-2015学年,在70000名小学生中,共选择1579名小学生参加这项横断面研究,采用两阶段整群随机抽样。测量学生的身高和体重,并计算他们的体重指数(BMI)。根据疾病控制中心(CDC)标准的BMI百分位数和SPSS计算的研究人群的百分位数,按年龄和性别确定体重状况。百分比超过95、85至95和小于5分别被认为是肥胖、超重和超重。采用信息表格收集年龄、性别、父母受教育程度、父母职业、居住地、学校类型、月收入、营养状况和开始补充喂养的时间,并用SPSS软件对数据进行分析。结果根据美国疾病控制与预防中心的BMI百分位数,学生肥胖、超重和体重不足的患病率分别为9%、10%和17%。年龄、学校类型、居住地和学生营养与体重异常之间存在显著相关性。此外,父母的教育程度、出生体重、开始补充喂养的时间、看电视和玩电脑游戏的时间以及体育活动率与学生的体重异常没有显著关系。结论体重异常是伊朗克尔曼市小学生最常见的健康问题之一。总体而言,超过35%的参与这项研究的儿童有某种形式的体重异常。在我们的社会中,体重不足被认为是一个健康问题,与肥胖和超重一样。
{"title":"Underweight, overweight, obesity and associated factors among elementary school children: A cross-sectional study in Kerman province, Iran","authors":"Mojgan Sanjari ,&nbsp;Ladan Amirkhosravi ,&nbsp;Seyed Ehsan Hosseini ,&nbsp;Mahzad tavakolinejad kermani ,&nbsp;Farzaneh Abdollahi ,&nbsp;Atefeh Maghfoori ,&nbsp;Mostafa Eghbalian","doi":"10.1016/j.obmed.2023.100477","DOIUrl":"https://doi.org/10.1016/j.obmed.2023.100477","url":null,"abstract":"<div><h3>Background</h3><p>Childhood weight abnormalities are often considered a global health issue with several consequences. This study was conducted to determine the prevalence of underweight, overweight and obesity, and also identify associated factors in elementary school children.</p></div><div><h3>Materials and methods</h3><p>A total of 1579 elementary school students out of 70000 in the academic year 2014–2015 were selected to participate in this cross-sectional study, using two-stage cluster random sampling. Students' height and weight were measured and their body mass index<span> (BMI) was calculated. Weight status was determined by age and sex according to BMI percentiles of the Center for Disease Control (CDC) standards and based on the percentiles calculated by SPSS in the studied population. Percentiles of more than 95, between 85 and 95, and less than 5 were considered as obese, overweight, and under-weight, respectively. Age, gender, level of parent's education, parent's occupation, place of residence, type of school, monthly income, nutritional status and time of starting complementary feeding, were collected by an information form. Data were analyzed by SPSS software.</span></p></div><div><h3>Results</h3><p>According to BMI percentile of CDC, the prevalence of obesity, overweight and underweight among students was 9%, 10% and 17%, respectively. A significant correlation was observed between age, type of school, place of residence, and students' nutrition with weight abnormalities. Also, parents’ education, birth weight, time of starting complementary feeding, hours of watching television and playing computer games, and physical activity rate had no significant relationship with weight abnormalities of students.</p></div><div><h3>Conclusion</h3><p>Weight abnormalities are one of the most common health problems among elementary school students living in Kerman city, Iran. Overall, more than 35% of children participated in this study had some form of weight abnormalities. Underweight is considered a health issue in our society, the same as obesity and overweight.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49719820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obesity Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1